A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects

NCT04973735 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: LY-CovMab

Sponsor

Luye Pharma Group Ltd.

Collaborators

[object Object]